| Name | Title | Contact Details |
|---|---|---|
Terry Patcheak |
VP, Research, Development and Advanced Engineering | Profile |
Rudi Barth |
Vice President of Quality | Profile |
Jeff Porter |
VP Quality & Continuous Improvement | Profile |
Ted Doering |
EVP, Global IT Strategy Advisor | Profile |
Family owned Oberto Brands, a leader in the meat snacks category, was established in Seattle in 1918 by an Italian immigrant family in pursuit of the American Dream. The Oberto family still remains an integral part of the business, and their hard work and dedication to great tasting products has grown the company from humble beginnings into what is today a national leader in meat snacks. The company is best known for its delicious, all natural, better-for-you jerky that is perfect for active lifestyles. Oberto Brands` products are found primarily in convenience stores, as well as on grocery aisles and club stores throughout the United States and Oberto.com.
Join us on our mission to eliminate dull flavors from the kitchen. Experiment with flavor using our 300+ fresh ingredients and bold spices.
Richelieu Foods, Inc. is one of the leading companies in the Manufacturing sector.
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.